QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hagman, J Articles by Storb, U Search for Related Content PubMed PubMed Citation Articles by Hagman, J Articles by Storb, U Social Bookmarking                   What's this?

Research Papers

A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.

Department of Molecular Genetics and Cell Biology, Chicago, Illinois 60637.

Abstract

As a first step toward defining the elements necessary for lambda immunoglobulin gene regulation, DNase I hypersensitive sites were mapped in the mouse lambda locus. A hypersensitive site found 15.5 kb downstream of C lambda 4 was present in all the B-cell but not in the T-cell lines tested. This site coincided with a strong B-cell-specific transcriptional enhancer (E lambda 2-4). This novel enhancer is active in myeloma cells, regardless of the status of endogenous lambda genes, but is inactive in a T-cell line and in fibroblasts. The enhancer E lambda 2-4 functions in the absence of the transcription factor NF kappa B, which is necessary for kappa enhancer function. No evidence could be found for NF kappa B binding by this element. Rearrangement of V lambda 2 to JC lambda 3 or JC lambda genes deletes E lambda 2-4; however, a second strong enhancer was found 35 kb downstream of C lambda 1, which cannot be eliminated by lambda gene rearrangements. The second lambda enhancer (E lambda 3-1) is 90% homologous to the E lambda 2-4 sequence in the region determined to comprise the active enhancer and likewise lacks the consensus binding site for NF kappa B. The data support a model for the independent activation of kappa and lambda gene expression based on locus-specific regulation at the enhancer level.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. M. Souto-Carneiro, R. Fritsch, N. Sepulveda, M. J. Lagareiro, N. Morgado, N. S. Longo, and P. E. Lipsky The NF-{kappa}B Canonical Pathway Is Involved in the Control of the Exonucleolytic Processing of Coding Ends during V(D)J Recombination J. Immunol., January 15, 2008; 180(2): 1040 - 1049. [Abstract] [Full Text] [PDF]

				S. Ma, A. Turetsky, L. Trinh, and R. Lu IFN Regulatory Factor 4 and 8 Promote Ig Light Chain {kappa} Locus Activation in Pre-B Cell Development J. Immunol., December 1, 2006; 177(11): 7898 - 7904. [Abstract] [Full Text] [PDF]

				K. Takacs, C. Du Roure, S. Nabarro, N. Dillon, J. H. McVey, Z. Webster, A. MacNeil, I. Bartok, C. Higgins, D. Gray, et al. The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes PNAS, November 16, 2004; 101(46): 16298 - 16303. [Abstract] [Full Text] [PDF]

				B. L. Schweitzer and R. P. DeKoter Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines J. Immunol., January 1, 2004; 172(1): 144 - 154. [Abstract] [Full Text] [PDF]

				R. Lu, K. L. Medina, D. W. Lancki, and H. Singh IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development Genes & Dev., July 15, 2003; 17(14): 1703 - 1708. [Abstract] [Full Text] [PDF]

				P. Oberdoerffer, T. I. Novobrantseva, and K. Rajewsky Expression of a Targeted {lambda}1 Light Chain Gene Is Developmentally Regulated and Independent of Ig{kappa} Rearrangements J. Exp. Med., May 5, 2003; 197(9): 1165 - 1172. [Abstract] [Full Text] [PDF]

				Z.-M. Liu, J. B. George-Raizen, S. Li, K. C. Meyers, M. Y. Chang, and W. T. Garrard Chromatin Structural Analyses of the Mouse Igkappa Gene Locus Reveal New Hypersensitive Sites Specifying a Transcriptional Silencer and Enhancer J. Biol. Chem., August 30, 2002; 277(36): 32640 - 32649. [Abstract] [Full Text] [PDF]

				G. Combriato and H.-G. Klobeck Regulation of Human Ig{lambda} Light Chain Gene Expression by NF-{kappa}B J. Immunol., February 1, 2002; 168(3): 1259 - 1266. [Abstract] [Full Text] [PDF]

				H. H. Bendall, M. L. Sikes, and E. M. Oltz Transcription Factor NF-{{kappa}}B Regulates Ig{{lambda}} Light Chain Gene Rearrangement J. Immunol., July 1, 2001; 167(1): 264 - 269. [Abstract] [Full Text] [PDF]

				A. V. Popov, X. Zou, J. Xian, I. C. Nicholson, and M. Bruggemann A Human Immunoglobulin lambda  Locus Is Similarly Well Expressed in Mice and Humans J. Exp. Med., May 17, 1999; 189(10): 1611 - 1620. [Abstract] [Full Text] [PDF]

				N. L. Farner, T. Dorner, and P. E. Lipsky Molecular Mechanisms and Selection Influence the Generation of the Human V{lambda}J{lambda} Repertoire J. Immunol., February 15, 1999; 162(4): 2137 - 2145. [Abstract] [Full Text] [PDF]

				E. Satyaraj and U. Storb Mef2 Proteins, Required for Muscle Differentiation, Bind an Essential Site in the Ig {lambda} Enhancer J. Immunol., November 1, 1998; 161(9): 4795 - 4802. [Abstract] [Full Text] [PDF]

				Q. Kong, L. Zhao, S. Subbaiah, and N. Maizels A {lambda} 3' Enhancer Drives Active and Untemplated Somatic Hypermutation of a {lambda}1 Transgene J. Immunol., July 1, 1998; 161(1): 294 - 301. [Abstract] [Full Text] [PDF]

				H. A. Young, D. M. Klinman, D. A. Reynolds, K. J. Grzegorzewski, A. Nii, J. M. Ward, R. T. Winkler-Pickett, J. R. Ortaldo, J. J. Kenny, and K. L. Komschlies Bone Marrow and Thymus Expression of Interferon-gamma Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies Blood, January 15, 1997; 89(2): 583 - 595. [Abstract] [Full Text] [PDF]

				C F Eisenbeis, H Singh, and U Storb Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes & Dev., June 1, 1995; 9(11): 1377 - 1387. [Abstract] [PDF]

				L Madisen and M Groudine Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes & Dev., September 15, 1994; 8(18): 2212 - 2226. [Abstract] [PDF]

				C A Klug, S J Gerety, P C Shah, Y Y Chen, N R Rice, N Rosenberg, and H Singh The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes & Dev., March 15, 1994; 8(6): 678 - 687. [Abstract] [PDF]

				Y Y Chen, L C Wang, M S Huang, and N Rosenberg An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes & Dev., March 15, 1994; 8(6): 688 - 697. [Abstract] [PDF]